The nutrition support practitioner may be called upon to help coordinate care at home for a patient who requires prolonged intravenous nutrition after he or she becomes stable enough to leave the hospital. This tutorial reviews the many concepts that must be considered to manage this type of care successfully.
DudrickSJWilmoreDWVarsHMRhodesJE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery. 1968;64:134-142.
2.
O’KeefeSBuchmanAFishbeinT. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006;4:6-10.
3.
HowardL. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology. 2006;130:S52-S59.
EmeryMStaffordJPearsonASteigerE. Venous access and catheter care. In: CoughlinKLDeChiccoRHamiltonC, eds. Cleveland Clinic Nutrition Support Team Manual. Cleveland, OH: Cleveland Clinic; 2011:121-142.
7.
PaauwJDBordersHIngallsN. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr. 2008;32:443-447.
8.
MoureauNPooleSMurdockMA. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol. 2002;13:1009-1016.
9.
O’GradyNPAlexanderMBurnsLA. Guidelines for the prevention of intravascular catheter related infections. Am J Infect Control. 2011;39:S1-S34.
10.
SteigerE. Dysfunction and thrombotic complications of vascular access devices. JPEN J Parenter Enteral Nutr. 2006;30:S70-S72.
11.
KusminskyRE. Complications of central venous catheterization. J Am Coll Surg. 2007;204:681-696.
12.
HadawayL. Flushing vascular access catheters: risks for infection transmission. Infect Control Resource. 2005;4:1-6.
13.
SpeerhasRRhodaK. Parenteral nutrition. In: CoughlinKLDeChiccoRHamiltonC, eds. Cleveland Clinic Nutrition Support Team Manual. Cleveland, OH: Cleveland Clinic; 2011:81-98.
14.
ChawlaRKBerryCJKutnerMHRudmanD. Plasma concentrations of transsulfuration pathway products during nasoenteral and intravenous hyperalimentation of malnourished patients. Am J Clin Nutr. 1985;42:577-584.
15.
BuchmanALAmentMESohelM. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo controlled trial. JPEN J Parenter Enteral Nutr. 2001;25;260-268.
16.
MillerDGWilliamsSKPalomboJDGriffinREBistrianBRBlackburnGL. Cutaneous application of safflower oil in preventing essential fatty acid deficiency in patients on home parenteral nutrition. Am J Clin Nutr. 1987;46:419-423.
17.
Kalista-RichardsMCookHC. Iron as an essential micronutrient. Support Line. 2002;24:17-22.
18.
KumpfVJ. Update on parenteral iron therapy. Nutr Clin Pract. 2003;18:318-326.
19.
SpeerhasRASeidnerDL. Measured versus estimated aluminum content of parenteral nutrition solutions. Am J Health Syst Pharm. 2007;64:740-746.
20.
TorresAJLandaJIMoreno-AzcoitaM. Somatostatin in the management of gastrointestinal fistulas. Arch Surg. 1992;127:97-99.
21.
IppolitiCChamplinRBugaziaN. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies. J Clin Oncol. 1997;15:3350-3354.
22.
SeidnerDLSpeerhasRA. Can octreotide be added to parenteral nutrition solutions? Point-counterpoint. Nutr Clin Pract. 1998;13:84-87.
23.
CavicchiMBeauPCrennP. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:523-532.
24.
Cohen-SolalMBaudoinCJolyF. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res. 2003;18:1989-1998.
25.
PironiLMorselliAMPertkiewiczM. Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr. 2002;21:289-296.
26.
KumpfVGervasioJ. Complications of parenteral nutrition. In: GottschlichMMDeLeggeMHMattoxTMuellerCWorthingtonP, eds. The A.S.P.E.N. Nutrition Support Core Curriculum: A Case Based Approach—The Adult Patient. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2007:323-339.
27.
PittetDTararaDWenzelRP. Nosocomial blood stream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
28.
OrsiGBDi StefanoLNoahN. Hospital acquired, laboratory confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol. 2002;23:190-197.
29.
TokarsJI.CooksonSTMcArthurMA. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med. 1999;131:340-347.
30.
KrzywdaEAAndrisDAEdmistonCEWallaceJR. Parenteral access devices. In: GottschlichMMDeLeggeMHMattoxTMuellerCWorthingtonP, eds. The A.S.P.E.N. Nutrition Support Core Curriculum: A Case Based Approach—The Adult Patient. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2007:300-322.
31.
FuhrmanMP. Complication management in parenteral nutrition. In: MatareseLEGottschlichMM, eds. Contemporary Nutrition Support Practice: A Clinical Guide. 2nd ed. St Louis, MO: Saunders Co; 2003:242-262.
32.
MermelLAAllonMBouzaE. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
33.
OpillaMTKirbyDFEdmondMB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2007;31:302-305.
34.
MouwEChessmanKLesherATaggeE. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Ped Surg. 2008;43:1025-1029.
35.
JohnBKKhanMASpeerhasR. Ethanol lock therapy in reducing catheter-related bloodstream infections in adult home parenteral nutrition patients: results of a retrospective study. JPEN J Parenter Enteral Nutr. 2012;36(5):603-610.
36.
JonesBAHullMARichardsonDS. Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure. J Ped Surg. 2010;45:1287-1293.
37.
MetcalfSCChambersSTPithieAD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect. 2004;49:20-22.
38.
CrinchCJHalfmannJACroneWCMakiDG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicon catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005;26:708-714.
39.
WongTCliffordVMcCallumZ. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition: a case series [published online October 5, 2011]. JPEN J Parenter Enteral Nutr. doi:10.1177/0148607111414713.
40.
OliveriaCNasarABrindleMWalesPW. Ethanol locks to prevent catheter related blood stream infections in parenteral nutrition: a meta-analysis. Pediatrics. 2002;129:318-329.
41.
CoberMPJohnsonCE. Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy. Am J Health Syst Pharm. 2007;64:2480-2482.
42.
BoraksPSealeJPriceJ. Prevention of central venous catheter associated thrombus using minidose warfarin in patients with haematological malignancies. Br J Haematol. 1998;101:483-486.
43.
BernMMLokichJJWallachSR. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med. 1990;112;423-428.
44.
DeChiccoRSeidnerDLBrunCSteigerEStaffordJLopezR. Tip position of long-term central venous access devices used for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2007;31:382-387.
45.
BaxterJPFayersPMMcKinleyAW. The clinical and psychometric validation of a questionnaire to assess the quality of life of adult patients treated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010;34:131-142.
46.
GuenterPRobinsonLDiMaria-GhaliliRALymanBSteigerEWinklerMF. Development of Sustain: A.S.P.E.N.’s national patient registry for nutrition care. JPEN J Parenter Enteral Nutr. 2012;36(4):399-406.
47.
CorriganMLJohnBKSteigerE. Parenteral nutrition. In: MullenGEMatareseLEPalmerM, eds. The Gastrointestinal and Liver Disease Nutrition Desk Reference. Boca Raton, FL: CRC Press; 2011:343-358.
48.
HwangTLueMChenL. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogasteroenterology. 2000;47:1347-1350.
